|
InhibitorSelect™ VEGF Signaling Pathway Inhibitor Panel
A panel containing 15 potent, selective, reversible, and cell-permeable inhibitors useful for the study of multiple signaling pathways activated by VEGF: 1 mg of Akt Inhibitor VIII, Isozyme-Selective, Akti-1/2 (Cat. No. 124018); 1 mg of Calcineurin Autoinhibitory Peptide, Cell-permeable (Cat. No. 207001); 5 mg of ET-18-OCH3 (Cat. No. 341207); 500 µg of Go 6983 (Cat. No. 365251); 100 mg of NG-Nitro-L-arginine Methyl Ester, Hydrochloride (Cat. No. 483125); 5 mg of p21-Activated Kinase Inhibitor III, IPA-3 (Cat. No. 506106); 500 µg of cPLA2α Inhibitor (Cat. No. 525143); 1 mg of PI-103 (Cat. No. 528100); 1 mg of PP2 (Cat. No. 529573); 1 mg of SB 203580 (Cat. No. 559389); 1 mg of U0126 (Cat. No. 662005); 5 mg of VEGFR Tyrosine Kinase Inhibitor V (Cat. No. 676501), 5 mg of VEGFR2 Kinase Inhibitor VI, Ki8751 (Cat. No. 676484); 1 mg of VEGFR2 Kinase Inhibitor III, SU5416 (Cat. No. 676487); 1 mg of ZM 336372 (Cat. No. 692000). Also provided with 15 ml of anhydrous DMSO (Cat. No. KP31817). Supplied with a data sheet.
产品信息
Form Solid
Protect from Light 是的
Hygrocopic 是的
Packaged under inert gas 是的
商店和运输信息
Storage -20°C
Ship Blue Ice Only
Standard Handling |